|

KQB198 Clinical Trials

2 actively recruiting trials across 2 locations

▼ -1 trial since July 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Kumquat Biosciences Inc.2

Indications

  • Cancer2
  • Gastro Intestinal Stromal Tumour1
  • GIST Metastatic Cancer1
  • GIST - Gastrointestinal Stromal Tumor1
  • CRC (Colorectal Cancer)1

Phoenix, Arizona1 trial

A Study to Investigate the Safety and Efficacy of KQB365 as Monotherapy and in Combination in Participants With Advanced Solid Malignancies

Mayo Clinic, Phoenix

Phase 1

Los Angeles, California1 trial

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

USC Norris Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.